Cargando…

Safety of off‐label dose reduction of non‐vitamin K antagonist oral anticoagulants in patients with atrial fibrillation

AIM: To investigate the effects of off‐label non‐vitamin K oral anticoagulant (NOAC) dose reduction compared with on‐label standard dosing in atrial fibrillation (AF) patients in routine care. METHODS: Population‐based cohort study using data from the United Kingdom Clinical Practice Research Datali...

Descripción completa

Detalles Bibliográficos
Autores principales:	van den Dries, Carline J., Pajouheshnia, Romin, van den Ham, Hendrika A., Souverein, Patrick, Moons, Karel G. M., Hoes, Arno W., Geersing, Geert‐Jan, van Doorn, Sander
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10091743/ https://www.ncbi.nlm.nih.gov/pubmed/36102068 http://dx.doi.org/10.1111/bcp.15534

Ejemplares similares

The Number of Concomitant Drugs and the Safety of Direct Oral Anticoagulants in Routine Care Patients with Atrial Fibrillation
por: van den Dries, Carline J., et al.
Publicado: (2020)

Clinical consequences of off-label reduced dosing of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: a systematic review and meta-analysis
por: Joosten, Linda P T, et al.
Publicado: (2023)

Managing the Increasing Burden of Atrial Fibrillation through Integrated Care in Primary Care: A Cost-Effectiveness Analysis
por: van den Dries, Carline J., et al.
Publicado: (2023)

Integrated management of atrial fibrillation including tailoring of anticoagulation in primary care: study design of the ALL-IN cluster randomised trial
por: van den Dries, Carline J, et al.
Publicado: (2017)

Integrated management of atrial fibrillation in primary care: results of the ALL-IN cluster randomized trial
por: van den Dries, Carline J, et al.
Publicado: (2020)

Risk of cardiac and non-cardiac adverse events in community-dwelling older patients with atrial fibrillation: a prospective cohort study in the Netherlands
por: van Doorn, Sander, et al.
Publicado: (2018)

Safety of switching from vitamin K antagonist to non-vitamin K antagonist oral anticoagulant in frail elderly with atrial fibrillation: rationale and design of the FRAIL-AF randomised controlled trial
por: Joosten, Linda P T, et al.
Publicado: (2019)

Comparative effectiveness and safety of direct oral anticoagulants versus warfarin in UK patients with atrial fibrillation and type 2 diabetes: A retrospective cohort study
por: Rustem Gulluoglu, Fatma, et al.
Publicado: (2020)

Integrated care in patients with atrial fibrillation- a predictive heterogeneous treatment effect analysis of the ALL-IN trial
por: Trinks-Roerdink, Emmy M., et al.
Publicado: (2023)

The effects of misclassification in routine healthcare databases on the accuracy of prognostic prediction models: a case study of the CHA2DS2-VASc score in atrial fibrillation
por: van Doorn, S., et al.
Publicado: (2017)

Risk of major bleeding among users of direct oral anticoagulants combined with interacting drugs: A population‐based nested case–control study
por: Zhang, Yumao, et al.
Publicado: (2020)

Anticoagulants in frail elderly patients with atrial fibrillation: a delicate balance
por: Trinks-Roerdink, Emmy M., et al.
Publicado: (2023)

Comparing risk of major bleeding between users of different oral anticoagulants in patients with nonvalvular atrial fibrillation
por: Souverein, Patrick C., et al.
Publicado: (2020)

Accounting for treatment use when validating a prognostic model: a simulation study
por: Pajouheshnia, Romin, et al.
Publicado: (2017)

Incidence and individual risk prediction of post-COVID-19 cardiovascular disease in the general population: a multivariable prediction model development and validation study
por: la Roi-Teeuw, Hannah M, et al.
Publicado: (2023)

Atrial fibrillation: trends in prevalence and antithrombotic prescriptions in the community
por: Joosten, L. P. T., et al.
Publicado: (2022)

Benefit of integrated care in patients with atrial fibrillation- a predictive heterogeneous treatment effect analysis of the ALL-IN trial
por: Trinks-Roerdink, E M, et al.
Publicado: (2023)

Treatment use in prognostic model research: a systematic review of cardiovascular prognostic studies
por: Pajouheshnia, Romin, et al.
Publicado: (2017)

Major bleeding in users of direct oral anticoagulants in atrial fibrillation: A pooled analysis of results from multiple population‐based cohort studies
por: van den Ham, Hendrika A., et al.
Publicado: (2021)

Off‐target effects of oral anticoagulants – vascular effects of vitamin K antagonist and non‐vitamin K antagonist oral anticoagulant dabigatran etexilate
por: van Gorp, Rick H., et al.
Publicado: (2021)

COVID-19-isolatiespreekuren tijdens de ‘eerste golf’: Een beschrijving van de patiënten
por: van Royen, Florien, et al.
Publicado: (2021)

External validation and updating of prediction models of bleeding risk in patients with cancer receiving anticoagulants
por: Trinks-Roerdink, EM, et al.
Publicado: (2023)

Mapping the risk of infections in patients with multiple sclerosis: A multi-database study in the United Kingdom Clinical Practice Research Datalink GOLD and Aurum
por: Leung, Melissa WY, et al.
Publicado: (2022)

Effectiveness and Safety of Off-label Dosing of Non–vitamin K Antagonist Anticoagulant for Atrial Fibrillation in Asian Patients
por: Lee, Kwang-No, et al.
Publicado: (2020)

Validation of two age dependent D-dimer cut-off values for exclusion of deep vein thrombosis in suspected elderly patients in primary care: retrospective, cross sectional, diagnostic analysis
por: Schouten, Henrike J, et al.
Publicado: (2012)

Incidence of superficial venous thrombosis in primary care and risk of subsequent venous thromboembolic sequelae: a retrospective cohort study performed with routine healthcare data from the Netherlands
por: Geersing, Geert-Jan, et al.
Publicado: (2018)

Invited Commentary: Treatment Drop-in—Making the Case for Causal Prediction
por: Sperrin, Matthew, et al.
Publicado: (2021)

Diagnostic prediction models for suspected pulmonary embolism: systematic review and independent external validation in primary care
por: Hendriksen, Janneke M T, et al.
Publicado: (2015)

Real-life impact of clinical prediction rules for venous thromboembolism in primary care: a cross-sectional cohort study
por: van Maanen, Rosanne, et al.
Publicado: (2020)

Incidence of direct oral anticoagulant use in patients with nonvalvular atrial fibrillation and characteristics of users in 6 European countries (2008–2015): A cross‐national drug utilization study
por: Ibáñez, Luisa, et al.
Publicado: (2019)

A Renal Function Based Trade-Off Analysis of Non-vitamin K Antagonist Oral Anticoagulants in Nonvalvular Atrial Fibrillation
por: Zhou, Ling-Yun, et al.
Publicado: (2018)

Off-Label Underdosing or Overdosing of Non-vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation: A Meta-Analysis
por: Wu, Xiaojuan, et al.
Publicado: (2021)

Effect of tailoring anticoagulant treatment duration by applying a recurrence risk prediction model in patients with venous thromboembolism compared to usual care: A randomized controlled trial
por: Geersing, Geert-Jan, et al.
Publicado: (2020)

Performance of the Framingham risk models and pooled cohort equations for predicting 10-year risk of cardiovascular disease: a systematic review and meta-analysis
por: Damen, Johanna A., et al.
Publicado: (2019)

Empirical evidence of the impact of study characteristics on the performance of prediction models: a meta-epidemiological study
por: Damen, Johanna A A G, et al.
Publicado: (2019)

Cardiovascular vulnerability predicts hospitalisation in primary care clinically suspected and confirmed COVID-19 patients: A model development and validation study
por: van Royen, Florien S., et al.
Publicado: (2022)

Search Filters for Finding Prognostic and Diagnostic Prediction Studies in Medline to Enhance Systematic Reviews
por: Geersing, Geert-Jan, et al.
Publicado: (2012)

Correction: Search Filters for Finding Prognostic and Diagnostic Prediction Studies in Medline to Enhance Systematic Reviews
por: Geersing, Geert-Jan, et al.
Publicado: (2012)

Perceptions and Experiences of Atrial Fibrillation Patients on Their Condition and Oral Anticoagulant Treatment
por: Slavenburg, Marcel, et al.
Publicado: (2020)

Safe exclusion of pulmonary embolism using the Wells rule and qualitative D-dimer testing in primary care: prospective cohort study
por: Geersing, Geert-Jan, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_f9bpc4ihbiun9d87975r55kg2v